Viewing Study NCT02555761


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2025-12-24 @ 12:17 PM
Study NCT ID: NCT02555761
Status: COMPLETED
Last Update Posted: 2019-07-05
First Post: 2015-09-18
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Sponsor: Allergan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module